SLC1A4 and liver cancer: Meanwhile, the protein levels of β-catenin and EpCAM in Huh7 and HepG2 cells were decreased with the knockdown of SLC1A4 (Figure 2c), approving the promoting role of SLC1A4 in EMT of hepatic cancer cells [37–39].